TY - JOUR
T1 - Development and Validation of a Bedside Risk Assessment for Sustained Prescription Opioid Use after Surgery
AU - Chaudhary, Muhammad Ali
AU - Bhulani, Nizar
AU - De Jager, Elzerie C.
AU - Lipsitz, Stuart
AU - Kwon, Nicollette K.
AU - Sturgeon, Daniel J.
AU - Trinh, Quoc Dien
AU - Koehlmoos, Tracey
AU - Haider, Adil H.
AU - Schoenfeld, Andrew J.
N1 - Funding Information:
Funding/Support: This study was funded through a grant from the US Department of Defense, Defense Health Agency (grant HU0001-11-1-0023).
Funding Information:
Administrative, technical, or material support: Chaudhary, Bhulani, de Jager, Kwon, Koehlmoos, Haider, Schoenfeld. Supervision: Lipsitz, Trinh, Koehlmoos, Haider, Schoenfeld. Conflict of Interest Disclosures: Dr Chaudhary reported grants from the Henry M. Jackson Foundation for the Advancement of Military Medicine during the conduct of the study. Dr de Jager reported support from the National Institute on Minority Health and Health Disparities of the National Institutes of Health (grant 5RO1MD011695-02) and support from an Australian Government Research Training Program Scholarship. Dr Trinh reported personal fees from Astellas, Bayer, Janssen, and Insightec, and grants and personal fees from Intuitive Surgical outside the submitted work. Dr Schoenfeld reported grants from the National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases and the Orthopaedic Research and Education Foundation; nonfinancial support from the Centers for Medicare & Medicaid Services Office of Minority Health; and personal fees from Wolters Kluwer, Springer, and the Journal of Bone and Joint Surgery outside the submitted work. No other disclosures were reported.
Publisher Copyright:
© 2019 JAMA Network Open. All rights reserved.
PY - 2019/7/10
Y1 - 2019/7/10
N2 - Importance: The increased use of prescription opioid medications has contributed to an epidemic of sustained opioid use, misuse, and addiction. Adults of working age are thought to be at greatest risk for prescription opioid dependence. Objective: To develop a risk score (the Stopping Opioids After Surgery score) for sustained prescription opioid use after surgery in a working-age population using readily available clinical information. Design, Setting, and Participants: In this case-control study, claims from TRICARE (the insurance program of the US Department of Defense) for working-age adult (age 18-64 years) patients undergoing 1 of 10 common surgical procedures from October 1, 2005, to September 30, 2014, were queried. A logistic regression model was used to identify variables associated with sustained prescription opioid use. The point estimate for each variable in the risk score was determined by its β coefficient in the model. The risk score for each patient represented the summed point totals, ranging from 0 to 100, with a lower score indicating lower risk of sustained prescription opioid use. Data were analyzed from September 25, 2018, to February 5, 2019. Exposures: Exposures were age; race; sex; marital status; socioeconomic status; discharge disposition; procedure intensity; length of stay; intensive care unit admission; comorbid diabetes, liver disease, renal disease, malignancy, depression, or anxiety; and prior opioid use status. Main Outcomes and Measures: The primary outcome was sustained prescription opioid use, defined as uninterrupted use for 6 months following surgery. A risk score for each patient was calculated and then used as a predictor of sustained opioid use after surgical intervention. The area under the curve and the Brier score were used to determine the accuracy of the scoring system and the Hosmer-Lemeshow goodness-of-fit test was used to evaluate model calibration. Results: Of 86356 patients in the analysis (48827 [56.5%] male; mean [SD] age, 46.5 [14.5] years), 6365 (7.4%) met criteria for sustained prescription opioid use. The sample used for model generation consisted of 64767 patients, while the validation sample had 21589 patients. Prior opioid exposure was the factor most strongly associated with sustained opioid use (odds ratio, 13.00; 95% CI, 11.87-14.23). The group with the lowest scores (<31) had a mean (SD) 4.1% (2.5%) risk of sustained opioid use; those with intermediate scores (31-50) had a mean (SD) risk of 14.9% (6.3%); and those with the highest scores (>50) had a mean (SD) risk of 35.8% (3.6%). Conclusions and Relevance: This study developed an intuitive and accessible opioid risk assessment applicable to the care of working-age patients following surgery. This tool is scalable to clinical practice and can potentially be incorporated into electronic medical record platforms to enable automated calculation and clinical alerts that are generated in real time.
AB - Importance: The increased use of prescription opioid medications has contributed to an epidemic of sustained opioid use, misuse, and addiction. Adults of working age are thought to be at greatest risk for prescription opioid dependence. Objective: To develop a risk score (the Stopping Opioids After Surgery score) for sustained prescription opioid use after surgery in a working-age population using readily available clinical information. Design, Setting, and Participants: In this case-control study, claims from TRICARE (the insurance program of the US Department of Defense) for working-age adult (age 18-64 years) patients undergoing 1 of 10 common surgical procedures from October 1, 2005, to September 30, 2014, were queried. A logistic regression model was used to identify variables associated with sustained prescription opioid use. The point estimate for each variable in the risk score was determined by its β coefficient in the model. The risk score for each patient represented the summed point totals, ranging from 0 to 100, with a lower score indicating lower risk of sustained prescription opioid use. Data were analyzed from September 25, 2018, to February 5, 2019. Exposures: Exposures were age; race; sex; marital status; socioeconomic status; discharge disposition; procedure intensity; length of stay; intensive care unit admission; comorbid diabetes, liver disease, renal disease, malignancy, depression, or anxiety; and prior opioid use status. Main Outcomes and Measures: The primary outcome was sustained prescription opioid use, defined as uninterrupted use for 6 months following surgery. A risk score for each patient was calculated and then used as a predictor of sustained opioid use after surgical intervention. The area under the curve and the Brier score were used to determine the accuracy of the scoring system and the Hosmer-Lemeshow goodness-of-fit test was used to evaluate model calibration. Results: Of 86356 patients in the analysis (48827 [56.5%] male; mean [SD] age, 46.5 [14.5] years), 6365 (7.4%) met criteria for sustained prescription opioid use. The sample used for model generation consisted of 64767 patients, while the validation sample had 21589 patients. Prior opioid exposure was the factor most strongly associated with sustained opioid use (odds ratio, 13.00; 95% CI, 11.87-14.23). The group with the lowest scores (<31) had a mean (SD) 4.1% (2.5%) risk of sustained opioid use; those with intermediate scores (31-50) had a mean (SD) risk of 14.9% (6.3%); and those with the highest scores (>50) had a mean (SD) risk of 35.8% (3.6%). Conclusions and Relevance: This study developed an intuitive and accessible opioid risk assessment applicable to the care of working-age patients following surgery. This tool is scalable to clinical practice and can potentially be incorporated into electronic medical record platforms to enable automated calculation and clinical alerts that are generated in real time.
UR - http://www.scopus.com/inward/record.url?scp=85069315308&partnerID=8YFLogxK
U2 - 10.1001/jamanetworkopen.2019.6673
DO - 10.1001/jamanetworkopen.2019.6673
M3 - Article
C2 - 31290987
AN - SCOPUS:85069315308
SN - 2574-3805
VL - 2
JO - JAMA network open
JF - JAMA network open
IS - 7
M1 - e196673
ER -